Abstract

The role of Sx of the primary tumor remains highly debatable in de novo stage IV BC. We aimed to assess Overall Survival (OS) among de novo metastatic BC pts who underwent Sx of the primary tumor ≤9 months (m) after diagnosis vs pts who did not, adjusting for prognostic factors.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call